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Background
Retroperitoneal sarcomas are rare malignant tumours
with aggressive course of disease and high local recurrence
rate. The evaluation and treatment of retroperitoneal sar-
comas are challenging because the tumours are relatively
rare and frequently present with advanced disease in an
anatomically complex location. We analyzed the treat-
ment and survival in 96 patients with primary or recurrent
retroperitoneal sarcoma (RPS).
Materials and methods
Between 1991 and 2003, 98 patients with RPS were
treated at the Instituto Nacional De Cancerologia of Méx-
ico. We retrospectively evaluated clinicopathological data
from 96 patients in a single institution. We examined the
treatment and outcome. Survival curves were generated
using the Kaplan-Meier and the log rank test.
Results
The median age at diagnosis was 47 years (range 17–81).
57 women and 41 men. The mean time following was 30
month (m). At diagnosis 30 patients had metastasis with
hepatic metastasis in 14% of all cases, followed by lung
(9%). Liposarcoma was the most common type of histol-
ogy (34%), followed by leiomyosarcoma (20%). The
mean size of tumor was 17 centimeter. We removed surgi-
cally in 87 patients and 11 patients were treated in other
institutions. 42% multivisceral resection. Only in 62
patients were valuable status of the surgical margins. R0
resection was made in 24 patients, R1 resection in 14 and
R2 in 24 patients. 37 patients we treated with adjuvant
radiotherapy (RT). The local recurrence was present 36%.
The overall survival (OS) was 39 m for low grade vs 29 m
by high grade (P = NS). The patients treatment with RT
surviving 41 m vs 33 m (P = 0.03) The OS in patients
treated with surgery in the institution was 42 m vs 10 m in
patients treated outside (P = 0.01). At following 47
patients were lost.
Conclusion
The treatment of patients with RPS remains unsatisfac-
tory. Aggressive surgery is recommended in the majority
of the cases. The adjuvant RT seems to be that impacts in
the overall survival. Our results indicate that the patients
with RPS should be treated in institutions specialized and
with a high experience in the multidisciplinary manage-
ment.
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